What technique is used to allow 99mTc-pertechnetate to permeate red cell membranes during tagging?

Prepare for the Nuclear Medicine Exit Exam. Use flashcards and multiple-choice questions with detailed explanations for each query. Get exam ready!

The technique that allows 99mTc-pertechnetate to permeate red cell membranes during tagging involves the utilization of stannous chloride. Stannous chloride serves as a reducing agent, which is key for the effective labeling of red blood cells.

When 99mTc-pertechnetate is introduced into the body, it is initially present as a pertechnetate ion. Red blood cells need to be tagged with technetium for imaging studies, and this requires the technetium to enter the cells. Stannous ions, provided by stannous chloride, facilitate the reduction of the technetium from its +7 oxidation state in pertechnetate to a lower oxidation state, allowing it to bind to the red blood cells.

This binding process is crucial for achieving effective imaging of blood flow and cardiac function in nuclear medicine studies. The reduction enables the technetium to integrate into the red blood cell structures, making it visible on imaging without compromising cell integrity.

The other options, while they may relate to different aspects of the process, do not directly address the mechanism by which technetium crosses red cell membranes for tagging. For instance, direct infusion into the bloodstream does not account for the need for the technet

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy